Prostate News Archive
15-Apr-2011
Prostate cancer screening higher in older, not middle-aged, men
prostate-cancer screening is at the center of a medical divide, with some medical experts saying men should be screened frequently and others saying too many are screened and that the false alarms aren?t worth the trouble. But both sides can agree on one thing: There?s little benefit in screening men with short life expectancies for what is often a slow-growing cancer. Does Prostate Cancer Screening Reduce Mortality Rates?
NEW YORK, April 14, 2011 /PRNewswire/ -- Dr. David Samadi, Vice Chairman, Department Urology, and Chief of Robotics and Minimally Invasive Surgery at The Mount Sinai Medical Center in New York City , expressed concern today regarding the conclusions of a study published this month in the British Medical Journal ( BMJ ). Following a group of 9,000 men for 20 years; 1,500 of whom were screened for ... Prostate screenings don?t save lives: study
PROSTATE cancer screening does not save lives and are more trouble than they are worth, according to a report in the British Medical Journal. More evidence for waiting to treat prostate cancer
For older men with low-risk prostate cancer, a new study adds to evidence that closely watching the tumor instead of immediately treating it may be a reasonable option. Drug May Double Prostate Cancer Survival
A biologic agent, tasquinimod, could help men with prostate cancer who are running out of options.
Back to Prostate News Archive
